Emerald Medical Applications Corp (OTCQB: MRLA) Appoints Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to its Scientific Advisory Board

PETACH TIKVA, Israel, May 18, 2016, MRLA, /PRNewswire/ Emerald Medical Applications Corp. (OTCQB: MRLA) ( Emerald or the Company ), the Israeli-based company engaged in the development and sale of DermaCompare™, its proprietary artificial intelligence technology and application for the early diagnosis of melanoma and other skin cancers, today announced that Dr. Ben-Zion Weiner has joined the Company s Scientific Advisory Board. From 1975 to 2012, Dr. Weiner held executive positions with Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and its subsidiaries ( Teva ). He was The post Emerald Medical Applications Corp (OTCQB: MRLA) Appoints Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to its Scientific Advisory Board appeared first on Public Wire.
http://bit.ly/1XzUSRF

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: